These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38223305)

  • 41. Psychometric Properties of the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) in Public First Responders.
    Jeong HS; Park S; Lim SM; Ma J; Kang I; Kim J; Kim EJ; Choi YJ; Lim JH; Chung YA; Lyoo IK; Yoon S; Kim JE
    Subst Use Misuse; 2017 Jul; 52(8):1069-1075. PubMed ID: 28323556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a Computer-Based Format for the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) With University Students.
    Christoff AO; Barreto HG; Boerngen-Lacerda R
    Subst Use Misuse; 2016 Jul; 51(9):1207-17. PubMed ID: 27191627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lifetime prevalence of psychotic and bipolar I disorders in a general population.
    Perälä J; Suvisaari J; Saarni SI; Kuoppasalmi K; Isometsä E; Pirkola S; Partonen T; Tuulio-Henriksson A; Hintikka J; Kieseppä T; Härkänen T; Koskinen S; Lönnqvist J
    Arch Gen Psychiatry; 2007 Jan; 64(1):19-28. PubMed ID: 17199051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination.
    Mitchell SG; Kelly SM; Gryczynski J; Myers CP; O'Grady KE; Kirk AS; Schwartz RP
    Subst Abus; 2014; 35(4):376-80. PubMed ID: 25036144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic performance of the Alcohol Use Disorders Identification Test (AUDIT) in detecting DSM-5 alcohol use disorders in the General population.
    Moehring A; Rumpf HJ; Hapke U; Bischof G; John U; Meyer C
    Drug Alcohol Depend; 2019 Nov; 204():107530. PubMed ID: 31505375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening bipolar disorders in a general hospital: Psychometric findings for the Persian version of mood disorder questionnaire and bipolar spectrum diagnostic scale.
    Shabani A; Mirzaei Khoshalani M; Mahdavi S; Ahmadzad-Asl M
    Med J Islam Repub Iran; 2019; 33():48. PubMed ID: 31456972
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of a substance and alcohol use assessment instrument among orphans and vulnerable children in Zambia using Audio Computer Assisted Self-Interviewing (ACASI).
    Kane JC; Murray LK; Bass JK; Johnson RM; Bolton P
    Drug Alcohol Depend; 2016 Sep; 166():85-92. PubMed ID: 27402551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative study of socio-demographic and substance use correlates in early-onset psychosis.
    Paruk S; Jhazbhay K; Singh K; Sartorius B; Burns JK
    Early Interv Psychiatry; 2018 Jun; 12(3):339-347. PubMed ID: 27038079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The eleven-item Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-11): Cross-cultural psychometric evaluation across 42 countries.
    Lee CT; Lin CY; Koós M; Nagy L; Kraus SW; Demetrovics Z; Potenza MN; Ballester-Arnal R; Batthyány D; Bergeron S; Billieux J; Burkauskas J; Cárdenas-López G; Carvalho J; Castro-Calvo J; Chen L; Ciocca G; Corazza O; Csako RI; Fernandez DP; Fernandez EF; Fujiwara H; Fuss J; Gabrhelík R; Gewirtz-Meydan A; Gjoneska B; Gola M; Grubbs JB; Hashim HT; Islam MS; Ismail M; Jiménez-Martínez M; Jurin T; Kalina O; Klein V; Költő A; Lee SK; Lewczuk K; Lochner C; López-Alvarado S; Lukavská K; Mayta-Tristán P; Milea I; Miller DJ; Orosová O; Orosz G; ; Ponce FP; Quintana GR; Garzola GCQ; Ramos-Diaz J; Rigaud K; Rousseau A; Scanavino MT; Schulmeyer MK; Sharan P; Shibata M; Shoib S; Sigre-Leirós V; Sniewski L; Spasovski O; Steibliene V; Stein DJ; Strizek J; Ünsal BC; Vaillancourt-Morel MP; Van Hout MC; Bőthe B
    J Psychiatr Res; 2023 Sep; 165():16-27. PubMed ID: 37453212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening for bipolar disorder among outpatients with substance use disorders.
    Nallet A; Weber B; Favre S; Gex-Fabry M; Voide R; Ferrero F; Zullino D; Khazaal Y; Aubry JM
    Eur Psychiatry; 2013 Mar; 28(3):147-53. PubMed ID: 21964483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) in relation to Alcohol Use Disorder (AUD) severity levels according to the brief DSM-5 AUD diagnostic assessment screener.
    Källmén H; Elgán TH; Wennberg P; Berman AH
    Nord J Psychiatry; 2019 Oct; 73(7):397-400. PubMed ID: 31347426
    [No Abstract]   [Full Text] [Related]  

  • 55. Accuracy of the Depression, Anxiety and Stress Scale (DASS-21) for Screening on Comorbid Internalizing Disorders among Youth in Substance Use Disorder Treatment.
    Moska C; Goudriaan AE; Blanken P; Hendriks V
    Eur Addict Res; 2023; 29(6):385-393. PubMed ID: 37848011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic accuracy of a two-item screen for drug use developed from the alcohol, smoking and substance involvement screening test (ASSIST).
    Tiet QQ; Leyva Y; Moos RH; Smith B
    Drug Alcohol Depend; 2016 Jul; 164():22-27. PubMed ID: 27234660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment.
    Delgadillo J; Payne S; Gilbody S; Godfrey C; Gore S; Jessop D; Dale V
    Drug Alcohol Depend; 2012 Sep; 125(1-2):37-42. PubMed ID: 22480667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lifetime prevalence and correlates of schizophrenia and disorders with psychotic symptoms in the general population of Izmir, Turkey].
    Binbay T; Alptekin K; Elbi H; Zağlı N; Drukker M; Aksu Tanık F; Ozkınay F; Onay H; Van Os J
    Turk Psikiyatri Derg; 2012; 23(3):149-60. PubMed ID: 22949284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of the Cannabis Abuse Screening Test in a sample of cannabis inpatients.
    Legleye S; Kraus L; Piontek D; Phan O; Jouanne C
    Eur Addict Res; 2012; 18(4):193-200. PubMed ID: 22472963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Systematic Review of Instruments to Identify Mental Health and Substance Use Problems Among Children in the Emergency Department.
    Newton AS; Soleimani A; Kirkland SW; Gokiert RJ
    Acad Emerg Med; 2017 May; 24(5):552-568. PubMed ID: 28145070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.